UBE2C and neoplasm: Treating tumor cell lines with the metabolically active enantiomer L-lactate for 15 min to identify previously unrecognized functions for the metabolite, the team found one of the most affected proteins to be UBE2C, a cell cycle-associated ubiquitin-conjugating enzyme.